CAS RN: 1435934-00-1
LDN 193189 hydrochloride
Product Availability
Choose a grade to view its available package options.
2 package records 2 with current stock 2 grade groups
Grade
10mM in Water (1)
99% (1)
In stock only
Batch No. Package Availability Warehouse Lead Time Inquiry
Batchno.20260131
1ml
In stock
Shanghai Inquiry
Batch No. Package Availability Warehouse Lead Time Inquiry
Batchno.20250630
1mg / 5mg / 25mg / 100mg
Confirm by inquiry
Shanghai 5-7 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 0.1g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 1435934-00-1
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
0.1g
≥95%
0
Out of Stock
Hong Kong
Inquiry
1435934-00-1 / 4-[6-(4-piperazin-1-ylphenyl)pyrazolo[1,5-a]pyrimidin-3-yl]quinoline;dihydrochloride
Standard CAS: 1435934-00-1
Multi CAS: No
Basic Information
copy
CAS
1435934-00-1 copy
Multi CAS
No copy
Molecular Formula
C25H24Cl2N6 copy
Molecular Weight
479.400000 copy
Exact Mass
478.143950 copy
SMILES
C1CN(CCN1)C2=CC=C(C=C2)C3=CN4C(=C(C=N4)C5=CC=NC6=CC=CC=C56)N=C3.Cl.Cl copy
InChI
InChI=1S/C25H22N6.2ClH/c1-2-4-24-22(3-1)21(9-10-27-24)23-16-29-31-17-19(15-28-25(23)31)18-5-7-20(8-6-18)30-13-11-26-12-14-30;;/h1-10,15-17,26H,11-14H2;2*1H copy
InChIKey
CMQXLLAILGGLRV-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
33 copy
Aromatic heavy atom count
25 copy
Fraction Csp3
0.16 copy
Rotatable bonds
3 copy
H-bond acceptors
6 copy
H-bond donors
1 copy
Molar refractivity
138.74 copy
TPSA
58.35 copy
LogP / Solubility
WLOGP
4.86 copy
MLOGP
4.31 copy
XLogP3
4.86 copy
Consensus LogP
4.68 copy
Log S (ESOL)
-6.24 copy
Class (ESOL)
Insoluble copy
Log S (Ali)
-7 copy
Class (Ali)
Insoluble copy
Log S (SILICOS-IT)
-7.17 copy
Class (SILICOS-IT)
Insoluble copy
ADME
GI absorption
High copy
BBB permeant
No copy
P-gp substrate
No copy
CYP1A2 inhibitor
Yes copy
CYP2C19 inhibitor
Yes copy
CYP2C9 inhibitor
Yes copy
CYP2D6 inhibitor
Yes copy
CYP3A4 inhibitor
Yes copy
Log Kp (skin permeation)
-2.19 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Leadlikeness
No copy
Synthetic Accessibility
4 copy